Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARFENTANIL vs CASIRIVIMAB\IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARFENTANIL vs CASIRIVIMAB\IMDEVIMAB: Safety Overview

Metric CARFENTANIL CASIRIVIMAB\IMDEVIMAB
Total FAERS Reports 185 4,248
Deaths Reported 166 137
Death Rate 89.7% 3.2%
Hospitalizations 18 1,351
Average Patient Age 38.6 yrs 54.3 yrs
% Female Patients 38.1% 55.4%